Vytrus Biotech SL (VYT)

Currency in EUR
17.00
+0.30(+1.80%)
Closed·
VYT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.8017.20
52 wk Range
5.2520.60
Key Statistics
Bid/Ask
16.60 / 17.20
Prev. Close
16.95
Open
17
Day's Range
16.8-17.2
52 wk Range
5.25-20.6
Volume
2.74K
Average Volume (3m)
9.5K
1-Year Change
183.3333%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VYT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Mar 25, 2026
EPS / Forecast
0.10 / --
Revenue / Forecast
2.33M / --
EPS Revisions
Last 90 days

VYT Income Statement

Compare VYT to Peers and Sector

Metrics to compare
VYT
Peers
Sector
Relationship
P/E Ratio
43.1x16.8x11.4x
PEG Ratio
0.240.000.03
Price/Book
-1.7x1.5x
Price / LTM Sales
12.9x1.8x0.9x
Upside (Analyst Target)
−52.7%8.6%23.4%
Fair Value Upside
Unlock10.2%13.4%Unlock

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin’s regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes; and Luminia Granatum that brightens skin, whitens dark spots, evens skin tone, and protects against oxidative stress. The company also provides Baolift that improves muscle tone and facial complexion; Elaya Renova that boosts hair tensegrity; Kannabia Sense, a prebiotic treatment that stimulates the skin microbiota to produce an in-situ postbiotic cocktail; Quora Noni to avoid the attack of skin harmful bacteria; Centella Reversa for facial complexion improvement; and Arabian Cotton to protect and repair cell structures against sun damage. In addition, it offers Photobiome, a prebiotic active that fights the skin photoageing process; Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Olea Vitae, a cellular oil against ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; and Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins. Further, the company provides technology solutions, such as plasma rich in cell factors; phyto-peptidic, phyto-lipidic, and phyto-glucidic fractions; and phyto-cell fusions, as well as Vytrus TV to create an audiovisual space with added value for cosmetic formulation. It exports its products. Vytrus Biotech, S.A. was incorporated in 2009 and is headquartered in Barcelona, Spain.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
163.09K2.17%2.72M
Other Institutional Investors
3.38M45.00%56.49M
Public Companies & Retail Investors
3.97M52.83%66.32M
Total
7.52M100.00%125.52M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FundSight S.A.8.46%635,89210,619
Zamit Capital S.C.A., SICAV-RAIF8.46%635,89210,619

People Also Watch

58.900
IDR
-2.29%
19.80
CLRE
-1.00%
16.600
SLRS
+0.45%
100.700
ACS
+2.18%
25.400
BBVA
+1.24%

FAQ

What Is the Vytrus Biotech (VYT) Stock Price Today?

The Vytrus Biotech stock price today is 17.00 EUR.

What Stock Exchange Does Vytrus Biotech Trade On?

Vytrus Biotech is listed and trades on the Madrid Stock Exchange.

What Is the Stock Symbol for Vytrus Biotech?

The stock symbol for Vytrus Biotech is "VYT."

What Is the Vytrus Biotech Market Cap?

As of today, Vytrus Biotech market cap is 127.40M EUR.

What Is Vytrus Biotech's Earnings Per Share (TTM)?

The Vytrus Biotech EPS (TTM) is 0.39.

From a Technical Analysis Perspective, Is VYT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vytrus Biotech Stock Split?

Vytrus Biotech has split 0 times.

How Many Employees Does Vytrus Biotech Have?

Vytrus Biotech has 44 employees.

What is the current trading status of Vytrus Biotech (VYT)?

As of Sep 04, 2026, Vytrus Biotech (VYT) is trading at a price of 17.00 EUR, with a previous close of 16.95 EUR. The stock has fluctuated within a day range of 16.80 EUR to 17.20 EUR, while its 52-week range spans from 5.25 EUR to 20.60 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.